SE417603B - Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper - Google Patents
Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaperInfo
- Publication number
- SE417603B SE417603B SE7703698A SE7703698A SE417603B SE 417603 B SE417603 B SE 417603B SE 7703698 A SE7703698 A SE 7703698A SE 7703698 A SE7703698 A SE 7703698A SE 417603 B SE417603 B SE 417603B
- Authority
- SE
- Sweden
- Prior art keywords
- deoxiprostaglandin
- aza
- procedure
- preparing derivatives
- therapeutical properties
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL49325A IL49325A (en) | 1976-03-31 | 1976-03-31 | 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7703698L SE7703698L (sv) | 1977-10-01 |
| SE417603B true SE417603B (sv) | 1981-03-30 |
Family
ID=11048789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7703698A SE417603B (sv) | 1976-03-31 | 1977-03-30 | Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4115401A (xx) |
| JP (1) | JPS52142060A (xx) |
| BE (1) | BE852941A (xx) |
| CA (1) | CA1074804A (xx) |
| CH (2) | CH624101A5 (xx) |
| DD (1) | DD130352A5 (xx) |
| DE (1) | DE2714129A1 (xx) |
| ES (1) | ES457385A1 (xx) |
| FR (1) | FR2346332A1 (xx) |
| GB (1) | GB1574246A (xx) |
| HU (1) | HU178040B (xx) |
| IL (1) | IL49325A (xx) |
| IT (1) | IT1075373B (xx) |
| NL (1) | NL7703503A (xx) |
| NO (1) | NO149428C (xx) |
| PL (3) | PL108289B1 (xx) |
| SE (1) | SE417603B (xx) |
| SU (3) | SU676162A3 (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5536475A (en) * | 1978-07-11 | 1980-03-14 | Glaxo Group Ltd | Prostanoid compound |
| US4320136A (en) * | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
| US4456613A (en) * | 1982-12-27 | 1984-06-26 | E. I. Du Pont De Nemours And Company | 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof |
| US4530933A (en) * | 1982-12-27 | 1985-07-23 | E. I. Du Pont De Nemours And Company | 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents |
| OA12117A (en) | 1999-12-22 | 2006-05-04 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis. |
| PT1339678E (pt) * | 2000-11-27 | 2007-11-30 | Pfizer Prod Inc | Agonistas selectivos do receptor ep4 no tratamento de osteoporose |
| AU2002328338C1 (en) * | 2001-07-16 | 2009-01-08 | Ono Pharmaceutical Co., Ltd | 2 pyrrolidone derivatives as prostanoid agonists |
| BR0211201A (pt) | 2001-07-16 | 2004-07-13 | Hoffmann La Roche | Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero |
| TWI313608B (en) | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
| JP4547912B2 (ja) | 2002-03-05 | 2010-09-22 | 小野薬品工業株式会社 | ８−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤 |
| CA2479222A1 (en) * | 2002-03-18 | 2003-09-25 | Pfizer Products Inc. | Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension |
| MXPA05007341A (es) * | 2003-01-10 | 2005-09-30 | Hoffmann La Roche | Derivados de 2-piperidona como agonistas de prostaglandina. |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US20080058375A1 (en) * | 2004-01-08 | 2008-03-06 | Elworthy Todd R | 2-Piperidone derivatives as prostaglandin antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975399A (en) * | 1974-08-06 | 1976-08-17 | E. I. Du Pont De Nemours And Company | 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones |
-
1976
- 1976-03-31 IL IL49325A patent/IL49325A/xx unknown
-
1977
- 1977-03-28 BE BE176164A patent/BE852941A/xx not_active IP Right Cessation
- 1977-03-28 GB GB12991/77A patent/GB1574246A/en not_active Expired
- 1977-03-29 DD DD7700198124A patent/DD130352A5/xx unknown
- 1977-03-29 PL PL1977210102A patent/PL108289B1/pl unknown
- 1977-03-29 PL PL1977197005A patent/PL107643B1/pl unknown
- 1977-03-29 PL PL1977210101A patent/PL107544B1/pl unknown
- 1977-03-30 HU HU77LA913A patent/HU178040B/hu unknown
- 1977-03-30 SE SE7703698A patent/SE417603B/xx unknown
- 1977-03-30 NO NO771134A patent/NO149428C/no unknown
- 1977-03-30 CH CH400377A patent/CH624101A5/fr not_active IP Right Cessation
- 1977-03-30 DE DE19772714129 patent/DE2714129A1/de not_active Withdrawn
- 1977-03-30 CA CA275,134A patent/CA1074804A/en not_active Expired
- 1977-03-31 JP JP3742877A patent/JPS52142060A/ja active Pending
- 1977-03-31 US US05/783,284 patent/US4115401A/en not_active Expired - Lifetime
- 1977-03-31 ES ES457385A patent/ES457385A1/es not_active Expired
- 1977-03-31 FR FR7709650A patent/FR2346332A1/fr active Granted
- 1977-03-31 NL NL7703503A patent/NL7703503A/xx not_active Application Discontinuation
- 1977-03-31 SU SU772465855A patent/SU676162A3/ru active
- 1977-03-31 IT IT21906/77A patent/IT1075373B/it active
-
1978
- 1978-03-30 SU SU782594353A patent/SU837321A3/ru active
- 1978-03-30 SU SU782595450A patent/SU715019A3/ru active
-
1980
- 1980-09-17 CH CH697780A patent/CH628032A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52142060A (en) | 1977-11-26 |
| SE7703698L (sv) | 1977-10-01 |
| SU676162A3 (ru) | 1979-07-25 |
| IT1075373B (it) | 1985-04-22 |
| CA1074804A (en) | 1980-04-01 |
| PL107643B1 (pl) | 1980-02-29 |
| DE2714129A1 (de) | 1977-10-13 |
| US4115401A (en) | 1978-09-19 |
| NO149428C (no) | 1984-04-18 |
| NL7703503A (nl) | 1977-10-04 |
| BE852941A (fr) | 1977-09-28 |
| CH628032A5 (fr) | 1982-02-15 |
| PL197005A1 (pl) | 1978-10-09 |
| NO771134L (no) | 1977-10-03 |
| FR2346332B1 (xx) | 1980-05-09 |
| PL108289B1 (pl) | 1980-03-31 |
| IL49325A (en) | 1979-11-30 |
| ES457385A1 (es) | 1978-02-01 |
| HU178040B (en) | 1982-02-28 |
| SU715019A3 (ru) | 1980-02-05 |
| PL107544B1 (pl) | 1980-02-29 |
| CH624101A5 (xx) | 1981-07-15 |
| FR2346332A1 (fr) | 1977-10-28 |
| IL49325A0 (en) | 1976-05-31 |
| DD130352A5 (de) | 1978-03-22 |
| GB1574246A (en) | 1980-09-03 |
| NO149428B (no) | 1984-01-09 |
| SU837321A3 (ru) | 1981-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE423994B (sv) | Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra | |
| SE7700051L (sv) | Forfarande for framstellning av l-(substituerd amino) alkanoyl-2-(dibesoxazepin-10-karbonyl)hydraziner och derivat derav | |
| SE436741B (sv) | Forfarande for framstellning av 15-deoxi-16-substituerade prostansyror och derivat derav | |
| SE417603B (sv) | Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper | |
| NO794317L (no) | Fremgangsmaate for fremstilling av pyrido-indolderivater | |
| SE7606224L (sv) | Forfarande for framstellning av heterocykliska acylaminoderivat | |
| NO821847L (no) | Fremgangsmaate for fremstilling av gamma-pyron-derivater | |
| SE7803035L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| SE423813B (sv) | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper | |
| NO784382L (no) | Fremgangsmaate for fremstilling av tiazoldin-derivater | |
| SE421528B (sv) | Forfarande for framstellning av 8,8-disubstituerade 6-metylergoliner och derivat derav | |
| SE7707407L (sv) | Forfarande for framstellning av cefamderivat | |
| SE434263B (sv) | Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan | |
| NO771263L (no) | Fremgangsm}te for fremstilling av indol-naftyridin-derivater | |
| RO77308A (ro) | Procedeu pentru prepararea derivatiilor aminochinazolinei substituite | |
| NO780389L (no) | Fremgangsmaate for fremstilling av erytromycin-derivater | |
| NO792659L (no) | Fremgangsmaate for fremstilling av karbostyrilderivater | |
| SE7709402L (sv) | Forfarande for framstellning av tetrahydropyridinderivat | |
| NO801236L (no) | Fremgangsmaate for fremstilling av halogenderivater av isopropylaminopyrimidin | |
| SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| SE436496B (sv) | Forfarande for framstellning av dibensotiofenderivat | |
| NO801724L (no) | Fremgangsmaate for fremstilling av ergopeptin-derivater | |
| SE7702166L (sv) | Forfarande for framstellning av derivat av cyklopenta (b) tiofen | |
| SE406586B (sv) | Nytt forfarande for framstellning av 3-fenyl-indol-2-sarbonitril och derivat derav | |
| SE436128B (sv) | Forfarande for framstellning av aziridinderivat |